Pharmafile Logo

Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882

 Latest Content from PMHub 

What does HCP engagement look like in a post-Covid world?

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Nucleus Global launches new branding as it sets its sights on the future

Press Releases | March 1, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, has announced the launch of its new brand.With over 35 years of experience providing medical communications excellence to the...

White paper: Are we prepared for the influx of CAR-Ts?

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

Shining a light on rare diseases with ‘Noah’s Story’

Press Releases | February 28, 2022 | Resonant Group

In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.

Accession welcomes Graham Ridgway as Non-Executive Chairman

Press Releases | February 25, 2022 | Accession

Accession, a specialist pharma market access consulting and software company, announces the appointment of accomplished software CEO Graham Ridgway as Non-Executive Chairman.

Rare Disease Day – looking to the future with hope

Press Releases | February 25, 2022 | Nucleus Global

On this year’s Rare Disease Day, Amanda Henkel, VP, Strategy, Nucleus X Consulting (part of Nucleus Global), reflects on recent advances in the rare disease setting.

Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women’s health

Press Releases | February 25, 2022 | Thrive Agency

Unequal health outcomes have been a reality for women throughout the world for far too long. But change is finally happening.

Bedrock to raise awareness of Rare Disease Day 2022 with film ‘Noah’s Story’

Press Releases | February 25, 2022 | Resonant Group

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

Eating Disorders Awareness Week

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders